BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28195165)

  • 21. GDC-0449 improves the antitumor activity of nano-doxorubicin in pancreatic cancer in a fibroblast-enriched microenvironment.
    Zhou Q; Zhou Y; Liu X; Shen Y
    Sci Rep; 2017 Oct; 7(1):13379. PubMed ID: 29042665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel protein encoded by circular SMO RNA is essential for Hedgehog signaling activation and glioblastoma tumorigenicity.
    Wu X; Xiao S; Zhang M; Yang L; Zhong J; Li B; Li F; Xia X; Li X; Zhou H; Liu D; Huang N; Yang X; Xiao F; Zhang N
    Genome Biol; 2021 Jan; 22(1):33. PubMed ID: 33446260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic inhibitory effect of Smo inhibitor jervine and its combination with decitabine can target Hedgehog signaling pathway to inhibit myelodysplastic syndrome cell line.
    Zhao F; Wang J; Yao L; Qin YT; Tuerxun N; Wang H; Jiang M; Hao JP
    Hematology; 2021 Dec; 26(1):518-528. PubMed ID: 34314648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo.
    Wickström M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevåg OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI
    Int J Cancer; 2013 Apr; 132(7):1516-24. PubMed ID: 22949014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects.
    Wellbrock J; Latuske E; Köhler J; Wagner K; Stamm H; Vettorazzi E; Vohwinkel G; Klokow M; Uibeleisen R; Ehm P; Riecken K; Loges S; Thol F; Schubert C; Amling M; Jücker M; Bokemeyer C; Heuser M; Krauter J; Fiedler W
    Clin Cancer Res; 2015 May; 21(10):2388-98. PubMed ID: 25745035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of smoothened decreases proliferation of synoviocytes in rheumatoid arthritis.
    Zhu SL; Huang JL; Peng WX; Wu DC; Luo MQ; Li QX; Li ZX; Feng XX; Liu F; Wang MX; Chen WQ; Olsen N; Zheng SG
    Cell Mol Immunol; 2017 Feb; 14(2):214-222. PubMed ID: 26189371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting Hedgehog Pathway and DNA Methyltransferases in Uterine Leiomyosarcoma Cells.
    Garcia N; Al-Hendy A; Baracat EC; Carvalho KC; Yang Q
    Cells; 2020 Dec; 10(1):. PubMed ID: 33396427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma.
    Pak E; MacKenzie EL; Zhao X; Pazyra-Murphy MF; Park PMC; Wu L; Shaw DL; Addleson EC; Cayer SS; Lopez BG; Agar NYR; Rubin LL; Qi J; Merk DJ; Segal RA
    Neuro Oncol; 2019 Sep; 21(9):1150-1163. PubMed ID: 31111916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smoothened-antagonists reverse homogentisic acid-induced alterations of Hedgehog signaling and primary cilium length in alkaptonuria.
    Gambassi S; Geminiani M; Thorpe SD; Bernardini G; Millucci L; Braconi D; Orlandini M; Thompson CL; Petricci E; Manetti F; Taddei M; Knight MM; Santucci A
    J Cell Physiol; 2017 Nov; 232(11):3103-3111. PubMed ID: 28019670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo characterization of a novel Hedgehog signaling antagonist in human glioblastoma cell lines.
    Ferruzzi P; Mennillo F; De Rosa A; Giordano C; Rossi M; Benedetti G; Magrini R; Pericot Mohr Gl; Miragliotta V; Magnoni L; Mori E; Thomas R; Tunici P; Bakker A
    Int J Cancer; 2012 Jul; 131(2):E33-44. PubMed ID: 22072503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the hedgehog inhibitor GDC-0449, alone or in combination with dasatinib, on BCR-ABL-positive leukemia cells.
    Okabe S; Tauchi T; Tanaka Y; Katagiri S; Ohyashiki K
    Stem Cells Dev; 2012 Nov; 21(16):2939-48. PubMed ID: 22642671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced proliferation and increased apoptosis of the SGC‑7901 gastric cancer cell line on exposure to GDC‑0449.
    Wu C; Cheng J; Hu S; Deng R; Muangu YW; Shi L; Wu K; Zhang P; Chang W; Wang G; Tao K
    Mol Med Rep; 2016 Feb; 13(2):1434-40. PubMed ID: 26676867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Potent Antagonist of Smoothened in Hedgehog Signaling for Epilepsy.
    Fan J; Zhao Z; Liu R; Li H; He W; Wu J; Wang Y; Chen W
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, Synthesis and Biological Evaluation of novel Hedgehog Inhibitors for treating Pancreatic Cancer.
    Kumar V; Chaudhary AK; Dong Y; Zhong HA; Mondal G; Lin F; Kumar V; Mahato RI
    Sci Rep; 2017 May; 7(1):1665. PubMed ID: 28490735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sonidegib, a Smoothened Inhibitor, Promotes Apoptosis and Suppresses Proliferation of Natural Killer/T-Cell Lymphoma.
    Liu S; Li C; Xin P; Zheng Y; Peng Q; Xu Y; Luo Y; Wu Y; Zhu X
    Med Sci Monit; 2019 Nov; 25():8579-8586. PubMed ID: 31724562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the Hedgehog pathway in cancer: can the spines be smoothened?
    Ailles L; Siu LL
    Clin Cancer Res; 2011 Apr; 17(8):2071-3. PubMed ID: 21367749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gli-1 expression is associated with lymph node metastasis and tumor progression in esophageal squamous cell carcinoma.
    Mori Y; Okumura T; Tsunoda S; Sakai Y; Shimada Y
    Oncology; 2006; 70(5):378-89. PubMed ID: 17179732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of canonical Hedgehog signaling pathway inhibition in canine osteosarcoma.
    Baldanza VE; Rogic A; Yan W; Levine CB; Levine RA; Miller AD; McCleary-Wheeler AL
    PLoS One; 2020; 15(4):e0231762. PubMed ID: 32348319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hedgehog fights back: mechanisms of acquired resistance against Smoothened antagonists.
    Metcalfe C; de Sauvage FJ
    Cancer Res; 2011 Aug; 71(15):5057-61. PubMed ID: 21771911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The transcription factor GLI2 as a downstream mediator of transforming growth factor-β-induced fibroblast activation in SSc.
    Liang R; Šumová B; Cordazzo C; Mallano T; Zhang Y; Wohlfahrt T; Dees C; Ramming A; Krasowska D; Michalska-Jakubus M; Distler O; Schett G; Šenolt L; Distler JH
    Ann Rheum Dis; 2017 Apr; 76(4):756-764. PubMed ID: 27793816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.